Login / Signup

Glucagon-Like Peptide-1 Infusion Suppresses Aldosterone Levels in Healthy Normal-Weight Individuals: Double-Blind, Placebo-Controlled Crossover Study.

Maja BaretićVesna KušecIvana Pavlić-Renar
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
ClinicalTrials.gov Identifier: NCT02130778.
Keyphrases
  • placebo controlled
  • double blind
  • clinical trial
  • phase iii
  • phase ii
  • weight loss
  • body mass index
  • study protocol
  • phase ii study
  • low dose
  • signaling pathway
  • physical activity
  • angiotensin ii
  • weight gain
  • body weight